# A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA

> **NCT07140523** · PHASE2 · RECRUITING · sponsor: **Sirius Therapeutics Co., Ltd.** · enrollment: 450 (estimated)

## Conditions studied

- Venous Thromboembolism

## Interventions

- **DRUG:** SRSD107
- **DRUG:** enoxaparin

## Key facts

- **NCT ID:** NCT07140523
- **Lead sponsor:** Sirius Therapeutics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-16
- **Primary completion:** 2026-06-30
- **Final completion:** 2026-10-31
- **Target enrollment:** 450 (ESTIMATED)
- **Last updated:** 2026-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07140523

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07140523, "A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07140523. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*